Difference between revisions of "Melanotic Xp11 translocation renal cancer"

From Libre Pathology
Jump to navigation Jump to search
(tweak)
(+images)
Line 14: Line 14:
*[[Malignant melanoma]].
*[[Malignant melanoma]].
*[[Xp11.2 translocation carcinoma]].
*[[Xp11.2 translocation carcinoma]].
===Images===
<gallery>
Image: Melanotic Xp11.2 translocation renal cancer -- low mag.jpg | MXTRC - low mag.
Image: Melanotic Xp11.2 translocation renal cancer -- intermed mag.jpg | MXTRC - intermed. mag.
Image: Melanotic Xp11.2 translocation renal cancer -- high mag.jpg | MXTRC - high mag.
Image: Melanotic Xp11.2 translocation renal cancer -- very high mag.jpg | MXTRC - very high mag.
Image: Melanotic Xp11.2 translocation renal cancer - b -- low mag.jpg | MXTRC - low mag.
Image: Melanotic Xp11.2 translocation renal cancer - b -- intermed mag.jpg | MXTRC - intermed. mag.
Image: Melanotic Xp11.2 translocation renal cancer - b1 -- high mag.jpg | MXTRC - high mag.
Image: Melanotic Xp11.2 translocation renal cancer - b2 -- high mag.jpg | MXTRC - high mag.
</gallery>


==IHC==
==IHC==

Revision as of 05:11, 2 January 2018

Melanotic Xp11 translocation renal cancer is a very rare kidney tumour that is evolving as an entity.[1]

General

  • Evolving entity.[2][1]
  • Very rare.

Microscopic

Features:

DDx:

Images

IHC

  • TFE3 +ve.
  • Keratin -ve.

Molecular

  • TFE3 rearrangement.

See also

References

  1. 1.0 1.1 Rao, Q.; Shen, Q.; Xia, QY.; Wang, ZY.; Liu, B.; Shi, SS.; Shi, QL.; Yin, HL. et al. (Sep 2015). "PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.". Am J Surg Pathol 39 (9): 1181-96. doi:10.1097/PAS.0000000000000502. PMID 26274027.
  2. Argani, P.; Aulmann, S.; Karanjawala, Z.; Fraser, RB.; Ladanyi, M.; Rodriguez, MM. (Apr 2009). "Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.". Am J Surg Pathol 33 (4): 609-19. doi:10.1097/PAS.0b013e31818fbdff. PMID 19065101.